115 related articles for article (PubMed ID: 38664017)
1. Dose Reduction in Pediatric Oncology Patients with Delayed Total-Body [
Mingels C; Spencer BA; Nalbant H; Omidvari N; Rokni M; Rominger A; Sen F; Cherry SR; Badawi RD; Abdelhafez YG; Nardo L
J Nucl Med; 2024 Apr; ():. PubMed ID: 38664017
[TBL] [Abstract][Full Text] [Related]
2. Image quality and lesion detectability in low-dose pediatric
Zhao YM; Li YH; Chen T; Zhang WG; Wang LH; Feng J; Li C; Zhang X; Fan W; Hu YY
Eur J Nucl Med Mol Imaging; 2021 Oct; 48(11):3378-3385. PubMed ID: 33738519
[TBL] [Abstract][Full Text] [Related]
3. Head-to-head intra-individual comparison of total-body 2-[
Chen X; Hu P; Yu H; Tan H; He Y; Cao S; Zhou Y; Shi H
Eur Radiol; 2023 Nov; 33(11):7890-7898. PubMed ID: 37338551
[TBL] [Abstract][Full Text] [Related]
4. Image Quality and Quantitative PET Parameters of Low-Dose [
Calderón E; Schmidt FP; Lan W; Castaneda-Vega S; Brendlin AS; Trautwein NF; Dittmann H; la Fougère C; Kiefer LS
Diagnostics (Basel); 2023 Oct; 13(20):. PubMed ID: 37892061
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of pediatric malignancies using total-body PET/CT with half-dose [
Chen W; Liu L; Li Y; Li S; Li Z; Zhang W; Zhang X; Wu R; Hu D; Sun H; Zhou Y; Fan W; Zhao Y; Zhang Y; Hu Y
Eur J Nucl Med Mol Imaging; 2022 Oct; 49(12):4145-4155. PubMed ID: 35788704
[TBL] [Abstract][Full Text] [Related]
6. Exploration of the total-body PET/CT reconstruction protocol with ultra-low
Sui X; Tan H; Yu H; Xiao J; Qi C; Cao Y; Chen S; Zhang Y; Hu P; Shi H
EJNMMI Phys; 2022 Mar; 9(1):17. PubMed ID: 35239037
[TBL] [Abstract][Full Text] [Related]
7. Feasibility of acquisitions using total-body PET/CT with a half-dose [
Chen Z; Wang Y; Yang X; Li L; Huo Y; Yu X; Xiao X; Zhang C; Chen Y; Zhao H; Zhou Y; Huang G; Liu J; Chen R
Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):3961-3969. PubMed ID: 37535107
[TBL] [Abstract][Full Text] [Related]
8. Application of the long axial field-of-view PET/CT with low-dose [
Sachpekidis C; Pan L; Kopp-Schneider A; Weru V; Hassel JC; Dimitrakopoulou-Strauss A
Eur J Nucl Med Mol Imaging; 2023 Mar; 50(4):1158-1167. PubMed ID: 36474125
[TBL] [Abstract][Full Text] [Related]
9. Simulated Reduced-Count Whole-Body FDG PET: Evaluation in Children and Young Adults Imaged on a Digital PET Scanner.
Alves VPV; Brady S; Ata NA; Li Y; MacLean J; Zhang B; Sharp SE; Trout AT
AJR Am J Roentgenol; 2022 Dec; 219(6):952-961. PubMed ID: 35731102
[No Abstract] [Full Text] [Related]
10. Total-body PET/CT using half-dose FDG and compared with conventional PET/CT using full-dose FDG in lung cancer.
Tan H; Sui X; Yin H; Yu H; Gu Y; Chen S; Hu P; Mao W; Shi H
Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1966-1975. PubMed ID: 33244618
[TBL] [Abstract][Full Text] [Related]
11. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
12. A method to assess image quality for Low-dose PET: analysis of SNR, CNR, bias and image noise.
Yan J; Schaefferkoette J; Conti M; Townsend D
Cancer Imaging; 2016 Aug; 16(1):26. PubMed ID: 27565136
[TBL] [Abstract][Full Text] [Related]
13. Optimal clinical protocols for total-body 18F-FDG PET/CT examination under different activity administration plans.
Huang Y; Wang M; Jiang L; Wang L; Chen L; Wang Q; Feng J; Wang J; Xu W; Wu H; Han Y
EJNMMI Phys; 2023 Feb; 10(1):14. PubMed ID: 36808378
[TBL] [Abstract][Full Text] [Related]
14. Half-dose versus full-dose 18 F-FDG total-body PET/CT in patients with colorectal cancer.
Tan H; Mao W; Cao Y; Cai D; Sui X; Qi C; Yu H; Zhang Y; Shi H
Nucl Med Commun; 2022 Aug; 43(8):928-936. PubMed ID: 35634804
[TBL] [Abstract][Full Text] [Related]
15. Reduced count pediatric whole-body
Alves VPV; Ata NA; MacLean J; Sharp SE; Li Y; Brady S; Trout AT
Pediatr Radiol; 2024 Jan; 54(1):170-180. PubMed ID: 37962603
[TBL] [Abstract][Full Text] [Related]
16. Reproducibility of FDG PET/CT image-based cancer staging and standardized uptake values with simulated reduction of injected FDG dose or acquisition time.
Niederkohr RD; Hayden SP; Hamill JJ; Jones JP; Schaefferkoetter JD; Chiu E
Am J Nucl Med Mol Imaging; 2021; 11(5):428-442. PubMed ID: 34754613
[No Abstract] [Full Text] [Related]
17. Feasibility of Acquisitions Using Total-Body PET/CT with an Ultra-Low
Hu Y; Liu G; Yu H; Wang Y; Li C; Tan H; Chen S; Gu J; Shi H
J Nucl Med; 2022 Jun; 63(6):959-965. PubMed ID: 34593593
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of optimal acquisition duration or injected activity for pediatric 18F-FDG PET/CT.
Alessio AM; Sammer M; Phillips GS; Manchanda V; Mohr BC; Parisi MT
J Nucl Med; 2011 Jul; 52(7):1028-34. PubMed ID: 21680684
[TBL] [Abstract][Full Text] [Related]
19. Reducing Radiation Exposure to Paediatric Patients Undergoing [18F]FDG-PET/CT Imaging.
Kertész H; Beyer T; London K; Saleh H; Chung D; Rausch I; Cal-Gonzalez J; Kitsos T; Kench PL
Mol Imaging Biol; 2021 Oct; 23(5):775-786. PubMed ID: 33846898
[TBL] [Abstract][Full Text] [Related]
20. Simulation of Tracer Dose Reduction in
Seith F; Schmidt H; Kunz J; Küstner T; Gatidis S; Nikolaou K; la Fougère C; Schwenzer N
J Nucl Med; 2017 Oct; 58(10):1699-1705. PubMed ID: 28360205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
